Trials / Completed
CompletedNCT00913822
To Demonstrate the Relative Bioavailability of Desipramine Hydrochloride Tablets
Bioavailability of Desipramine Hydrochloride Tablets
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioavailability of Desipramine Hydrochloride tablets.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Desipramine Hydrochloride 100 mg Tablets (Cord Laboratories) | |
| DRUG | Norpramin 100 mg Tablets (Merrell Dow Pharmaceuticals, Inc.) |
Timeline
- Start date
- 1987-12-01
- Primary completion
- 1987-12-01
- Completion
- 1987-12-01
- First posted
- 2009-06-04
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00913822. Inclusion in this directory is not an endorsement.